Trials / Not Yet Recruiting
Not Yet RecruitingNCT06639334
The Q-REDUCE Study
A Quick Pathway for Patients With High pRobability of dislocatEd Hemi- or Total Hip Arthroplasty to Minimize the Time From Hospital aDmission to redUCtion of the prosthEsis
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- University of Southern Denmark · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to design a fast-track pathway for patients referred to the University Hospital of Southern Denmark, Esbjerg, with high probability of having a dislocated hip prosthesis with the primary aim to reduce the time from arrival to reduction and the total hospitalization time. Secondary aims are to * investigate whether quicker prosthesis reduction influences on hip function and quality of life afterwards * reduce the pain experience immediately and in the long term * increase patient satisfaction without changing the overall complication rate and readmission/mortality
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Fasttrack pathway for THA/HE prosthesis reduction | The purpose of this study is to design a fast-track pathway for patients referred to the University Hospital of Southern Denmark, Esbjerg, with high probability of having a dislocated hip prosthesis with the primary aim to reduce the time from arrival to reduction and the total hospitalization time. The intervention is changed logistic and work pathways at the hospital that should reduce time to reduction significantly. For detailed description we refer to the uploaded protocol. |
| OTHER | Standard pathway for THA/HE prosthesis reduction | Standard treatment for a dislocated THA/HA at our institution is education in general anesthesia at the operating theater. For detailed description we refer to the uploaded protocol. |
Timeline
- Start date
- 2024-11-01
- Primary completion
- 2026-08-31
- Completion
- 2027-08-31
- First posted
- 2024-10-15
- Last updated
- 2024-10-15
Source: ClinicalTrials.gov record NCT06639334. Inclusion in this directory is not an endorsement.